Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis
14.04.2010 - Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis
Pharmaxis today announced completion of its second six month, Phase 3 international trial assessing the effectiveness of Bronchitol in people with cystic fibrosis.